Insider Transactions in Q3 2022 at Liquidia Corp (LQDA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2022
|
Michael Kaseta CFO and COO |
BUY
Open market or private purchase
|
Direct |
8,000
+17.44%
|
$40,000
$5.99 P/Share
|
|
Sep 06
2022
|
Russell Schundler General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
32,600
+5.66%
|
$163,000
$5.65 P/Share
|
|
Sep 06
2022
|
Roger Jeffs Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
43,820
+21.52%
|
$219,100
$5.57 P/Share
|
|
Sep 06
2022
|
Caligan Partners LP Director |
BUY
Open market or private purchase
|
Indirect |
250,000
+2.29%
|
$1,250,000
$5.62 P/Share
|
|
Aug 31
2022
|
Russell Schundler General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,166
+0.95%
|
$8,664
$4.9 P/Share
|
|
Aug 31
2022
|
Scott Moomaw Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
2,160
+18.05%
|
$8,640
$4.9 P/Share
|
|
Aug 31
2022
|
Robert A Lippe Chief Operations Officer |
BUY
Open market or private purchase
|
Direct |
1,918
+1.92%
|
$7,672
$4.9 P/Share
|
|
Aug 31
2022
|
Michael Kaseta CFO and COO |
BUY
Open market or private purchase
|
Direct |
1,927
+6.06%
|
$7,708
$4.9 P/Share
|
|
Aug 31
2022
|
Roger Jeffs Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
993
+0.85%
|
$3,972
$4.9 P/Share
|
|
Jul 18
2022
|
Rajeev Saggar Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
93,834
+50.0%
|
-
|